2 martini wrote "I don't think CYDY gives a shit w
Post# of 157598

And by the lack of Investor Relations responses to basic shareholder queries, I don't think CYDY cares what any of us think.
But they should care. Misiu and Ohm and Mdilion and many others have a lot to offer, and they recognize a poor trial design when they see it. And in light of prior management performance, or lack of performance, it is not an unreasonable request to get some answers re: if we are or are not considering a trial revision to improve patient and drug performance outcomes.
Seems like a pretty basic request, and it should not be met with silence, certainly nor contempt.

